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Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MissouriABSTRACT EmrE is a small multidrug resistance transporter that has been well studied as a model for secondary active trans-
port. Because transport requires the protein to convert between at least two states open to opposite sides of the membrane, it is
expected that blocking these conformational transitions will prevent transport activity. We have previously shown that NMR can
quantitatively measure the transition between the open-in and open-out states of EmrE in bicelles. Now, we have used the anti-
parallel EmrE crystal structure to design a cross-link to inhibit this conformational exchange process. We probed the structural,
dynamic, and functional effects of this cross-link with NMR and in vivo efflux assays. Our NMR results show that our antiparallel
cross-link performs as predicted: dramatically reducing conformational exchange while minimally perturbing the overall structure
of EmrE and essentially trapping EmrE in a single state. The same cross-link also impairs ethidium efflux activity by EmrE in
Escherichia coli. This confirms the hypothesis that transport can be inhibited simply by blocking conformational transitions in
a properly folded transporter. The success of our cross-linker design also provides further evidence that the antiparallel crystal
structure provides a good model for functional EmrE.INTRODUCTIONMultidrug resistance (MDR) transporters, such as EmrE,
confer resistance to toxic substances by exporting them
out of the cell. This energy-dependent process requires the
protein to interconvert between inward- and outward-facing
states that are accessible to opposite sides of the membrane
(1). Over the last decade, crystal structures of several diverse
transporters have been determined in multiple states, as
predicted by the alternating access model. Together with
biochemical and functional assays, these structures support
the key hypothesis that conformational dynamics of trans-
porter proteins are critical for proper function (2–6). It is
thus generally expected that blocking this motion and pre-
venting the structural changes necessary for alternating ac-
cess will prevent substrate transport. However, it has been
difficult to test this hypothesis directly due to the difficulty
in measuring integral membrane protein dynamics. One tool
that has been used to prevent conformational exchange in
transporters is site-directed cross-linking based on structural
models of the different states in the transport cycle. Cross-
linking of several transporters at positions expected to be
close together in only one conformational state in the func-
tional cycle has been shown to abolish their function in
vivo, presumably due to blocking of required protein motion
(7–11). However, the effect of cross-linking on protein
structure and dynamics has not been directly measured to
confirm this hypothesis.
EmrE is a small multidrug resistance (SMR) transporter
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0006-3495/14/08/0613/8 $2.00dynamics, and function. As a SMR transporter, it is quite
small (110 aa) and functions as a dimer in the inner mem-
brane of Escherichia coli. Using solution NMR, our lab
has quantitatively measured the rate of EmrE interconvert-
ing between inward- and outward-facing conformations in
the presence of polyaromatic cation substrates (12,13).
With this tool, we can now directly test the hypothesis
that cross-linking blocks function by preventing protein
motion through direct NMR measurement of the effect of
cross-linking on EmrE structure and dynamics, coupled
with functional assays.
The topology of EmrE has been highly controversial.
Within the native environment of the E. coli inner mem-
brane, accessibility studies have consistently shown that
EmrE monomers are present in both orientations with equal
probability (14,15). With purified EmrE reconstituted into
lipid bilayers, cryo-electron microscopy and solid-state
NMR studies of EmrE reveal asymmetry within the 8-helix
bundle of the homodimer, but the topology could not be
determined from this data (16–19). The 3.8 A˚ resolution
x-ray crystal structure of EmrE purified in detergent has
a similar asymmetric structure with a clearly antiparallel
topology (20). Single molecule Fo¨rster resonance energy
transfer studies done with purified EmrE in isotropic bi-
celles confirm that the topology is also antiparallel under
these conditions, the same conditions used to measure the
conformational exchange rate by NMR (12). Finally, recent
studies of EmrE by blue-native polyacrylamide gel electro-
phoresis (PAGE) and in vivo tryptophan scanning suggest
that the antiparallel topology is more stable and the crystal
structure provides a good representation of the functional
state in the cell (20–22).http://dx.doi.org/10.1016/j.bpj.2014.06.030
614 Dutta et al.Because our own cross-linking and Fo¨rster resonance en-
ergy transfer experiments have demonstrated that EmrE is
exclusively antiparallel when purified under our standard
protocols (12), we have designed our experiments to test
the hypothesis that cross-linking blocks EmrE function by
preventing conformational exchange using the model of ex-
change within the antiparallel dimer (Fig. 1). In this model,
the two monomers within the asymmetric antiparallel EmrE
homodimer swap conformations when the dimer converts
between the open-in and open-out states. This mechanism
was first proposed by Fleishman et al. (23) and is supported
by our previous NMR studies in bicelles (12).
In this work, we have used NMR to observe the structural
and dynamic effects of antiparallel cross-linking on EmrE
in isotropic bicelles. Our results show that there is limited
structural perturbation but significant suppression of con-
formational exchange under these conditions. The same
antiparallel cross-linking in cells reduces ethidium efflux,
indicating that EmrE activity is impaired in its native envi-
ronment when cross-linked in an antiparallel fashion. Thus,
we demonstrate that the function of an SMR transporter can
be blocked by preventing the conformational dynamics of
the protein, as predicted by the single-site alternating access
model.MATERIALS AND METHODS
EmrE expression, purification, and reconstitution
Wild-type (WT) EmrE was expressed using a pET15b plasmid with an
N-terminal 6-His tag (a generous gift from Geoffrey Chang, Scripps
Research Institute) and purified as previously described (12). Briefly,2H+ Drug
2H+ Drug
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FIGURE 1 A model of conformational exchange in antiparallel, asym-
metric EmrE. Two monomers (yellow and red) exchange conformations
upon switching between the open-in and open-out states. Based on the anti-
parallel crystal structure (pdb 3B5D), Lys-22 and Ser-107 (blue and green
spheres) from opposite monomers should be cross-linked by the heterobi-
functional cross-linkers S-GMBS or SPDP (orange line) on the closed
face only where they are separated by a shorter distance than on the open
face. Due to the absence of the C-terminus in both monomers in the crystal
structure, imaginary lines are drawn to show the position of Ser-107. The
distances shown are the Ca distances between Lys-22 (monomer A or
monomer B) and Asn-102 (monomer B or monomer A) in open-in and
open-out states of EmrE. To see this figure in color, go online.
Biophysical Journal 107(3) 613–620BL21 (DE3) (Stratagene/Agilent Technologies, Santa Clara, CA) cells
transformed with the EmrE-containing plasmid were grown in M9 mini-
mal media with 100 mg/mL ampicillin and induced with IPTG at 17C
overnight. After harvesting the cells, they were lysed by sonication and
the membrane fraction was solubilized with 40 mM n-Dodecyl-b-D-mal-
toside (DDM) (Affymetrix Anatrace, Maumee, OH). EmrE was purified
using Ni-NTA resin (Novagen/EMD Millipore, Darmstadt, Germany)
and gel filtration chromatography in 10 mM DDM, with the His-tag
cleaved between the columns. Purified EmrE was then reconstituted
into 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) liposomes using
AMBERLITE (Supelco/Sigma-Aldrich, St. Louis, MO) and the liposomes
were broken into isotropic bicelles with the short chain lipid 1,2-dihexa-
noyl-sn-glycero-3-phosphocholine (DHPC) as previously described
(12,24). Single cysteine mutant S107C-EmrE for cross-linking was con-
structed using QUICKCHANGE (Stratagene/Agilent Technologies) and
purified using the same method. This mutant had the three native cysteines
mutated to serine (C39S, C41S, and C95S) in addition to the single
cysteine residue (S107C).In vitro chemical cross-linking experiments
Cross-linking experiments were carried out with 90 mM S107C-EmrE,
10 mM DDM, 20 mM potassium phosphate, 20 mM NaCl, 1 mM TCEP
at pH 7.0 for a maximum of 10 min in 37C followed by quenching
with b-mercaptoethanol at 20 the cross-linker concentration. The
cross-linked protein samples were run on sodium dodecyl sulfate-PAGE
(SDS-PAGE) and visualized by staining with Coomassie blue. Separate ex-
periments were performed with S-GMBS and the cell permeable cross-
linker SPDP. S-GMBS, sulfo-(N-[g-maleimidobutyryloxy] succinimide)
(Pierce, Thermo Scientific, Rockford, IL), and SPDP, (N-Succinimidyl
3-(2-pyridyldithio)-propionate) (Pierce, Thermo Scientific), are heterobi-
functional cross-linkers having a 6.8–7.3 A˚ spacer arm between functional
groups that react with one primary amine and cysteine sulfhydryl.NMR experiments
2D 1H-15N TROSY-HSQC spectra were acquired on a 700 MHz Varian
NMR spectrometer with a room temperature HCN probe. The samples
contained 1.0 mM 2H/15N-EmrE in isotropic bicelles (q ¼ 0.33, DLPC/
DHPC) 20 mM NaCl, 20 mM potassium phosphate, 2 mM TCEP,
2.5 mM tetraphenylphosphonium (TPPþ), pH 7.0, 45C. The cross-linking
efficiency was nearly 100% with S-GMBS under the conditions needed to
produce high concentrations NMR samples. Both non-cross-linked and
cross-linked protein samples were reconstituted in 400 mM isotropic bi-
celles (q ¼ 0.33, DLPC/DHPC) as described previously (12,24). The
ZZ-exchange experiments were performed using a modified TROSY-
selected ZZ-exchange pulse sequence (12,25) at 45C with 80 msec mix-
ing time, 144 scans per increment and 144 complex points in the indirect
dimension. All NMR spectra were processed and analyzed with NMRPipe
(26) and NMRView (27).In-cell transport assay
In-cell ethidium (Ethþ) efflux assays based on work from the laboratories of
Le Pecq and Schuldiner (28,29) were carried out in the BL21 (DE3) Gold
strain of E. coli. Cells were transformed with WT EmrE, S107C-EmrE,
S107CK22R-EmrE, or cysless-EmrE and grown in M9 media supple-
mented with 100 mg/mL ampicillin. At OD600¼ 0.4, overexpression was
induced with 0.33 mM IPTG for 30 min. 2 ml of bacterial culture was incu-
bated at 37C for 15 min with 5 mM cross-linker (S-GMBS or SPDP) or no
cross-linker and then the cells were harvested and washed three times with
2 ml M9 medium without antibiotics. The cells were resuspended in 2 ml
M9 with 2.5 mM ethidium bromide and 40mM CCCP, followed by
Cross-Linking Disrupts Dynamics 615incubation at 37C for an additional hour. Finally, the cells were spun down
and resuspended immediately in 2 mL M9 media with or without 40 mM
carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Ethþ fluorescence
was measured with excitation at 545 nm and emission at 610 nm.Analysis of in vivo cross-linked EmrE
EmrE was cross-linked in cells in the same manner as for the transport as-
says but with a larger volume of culture. The cells were harvested, lysed,
and fractionated. The cell debris and inclusion bodies were separated using
a low speed spin (10 min at 7000 g). Membranes were collected by centri-
fugation at 30,000 g for 1 h. Both the inclusion body and membrane frac-
tions were resuspended in an equal volume of lysis buffer. EmrE was
purified using Ni-NTA resin in 10 mM DDM without b-mercaptoethanol.
Equal volumes of each elution were mixed with SDS loading buffer and
incubated at room temperature for 30 min before loading onto 12% SDS-
PAGE gel (Bio-Rad Laboratories Inc., Hercules, CA). The protein was
visualized by staining with Oriole fluorescent dye (Bio-Rad Laboratories)
and monitored using ultraviolet (UV) light.RESULTS AND DISCUSSION
WT and S107C-EmrE are structurally and
dynamically similar
To export polyaromatic cations from the cytoplasm to the
periplasm EmrE needs to interconvert between open-in
and open-out states (12,23). Intermonomer cross-linking us-
ing cross-linkers having a short arm length may prevent the
interconversion process if the dimer can be trapped in one
state (Fig. 1). Note that in EmrE the open-in and open-out
dimer structures are identical except for their orientation
in the membrane because the two monomers in the antipar-
allel asymmetric homodimer swap conformations. This al-
lows the single crystal structure to be used as a model for
the entire conformational exchange process. We therefore
designed an antiparallel cross-link from S107C to K22
that can be cross-linked with a heterobifunctional cross-
linker. This distance changes from short (~16A˚) to long
(~20A˚) upon conformational exchange between the open-
in and open-out states. These distances were estimated by
measuring from Ca of K22 to Ca of N102, the last residue
present in both monomers of the crystal structure. We expect
that the distance from K22 to S107C is actually shorter on
the closed side of the protein due to two facts. i), The sensi-
tivity of chemical shifts in the C-terminal tail of monomer A
but not monomer B upon binding different ligands suggests
that the C-terminus extends back toward the substrate bind-
ing pocket on the closed face of the protein, which would
bring it closer to K22. ii), We have previously successfully
cross-linked this construct with S-GMBS, a heterobifunc-
tional cross-linker with a 7.3A˚ spacer arm (12,13).
Cross-linking of otherwise cysless S107C-EmrE with
S-GMBS occurs with nearly 100% efficiency in detergent
(12). The mutation K22R abolished cross-linking, demon-
strating that lysine 22 was cross-linked to the single cysteine
at position 107 in S107C-EmrE and confirming the antipar-
allel topology of the two monomers.To assess the effects of cross-linking on conformational
exchange in EmrE we first examined the otherwise cys-
less (C39S, C41S, C95S) S107C mutant of EmrE, referred
to as S107C-EmrE. Mutation of these residues did not alter
E. coli growth phenotype and functioned identically to
WT EmrE in an in vivo Ethþ resistance assay (see Fig. 4
A), consistent with previous reports (30). 2H/15N-S107C-
EmrE was purified and reconstituted into isotropic bicelles
with excess TPPþ for solution NMR experiments on the sub-
strate-bound state. The mutations alone did not significantly
alter the structure of the protein because only minimal
chemical shift perturbations are observed close to the sites
of mutation (Fig. 2, A and B). The number of peaks, the
chemical shift dispersion, and peak pattern are preserved.
We have previously shown that WT EmrE bound to TPPþ
interconverts between the open-in and open-out states under
these conditions with a rate of 4.85 0.5 s1 (12). Like WT
EmrE the S107C mutant showed crosspeaks due to the
conformational exchange at 80 msec mixing time in the
ZZ-exchange experiment (Fig. 2, C and D). The relative in-
tensity of the cross- and autopeaks is also similar to WT,
showing that S107C-EmrE has a comparable rate of confor-
mational exchange. These results confirm that S107C-EmrE
is similar to WT EmrE in terms of its structure, dynamics,
and function.Antiparallel cross-linking changes the dynamic
behavior of S107C-EmrE
To prevent conformational exchange of S107C-EmrE, we
cross-linked the protein with the antiparallel heterobifunc-
tional cross-linker S-GMBS. We confirmed our previous
finding, that S-GMBS cross-links the S107C sulfhydryl
group to the amino group of K22 with almost 100% effi-
ciency in DDM micelles (see Fig. 4 D) but the cross-linking
efficiency is reduced in bicelles (data not shown). This is
probably due to reduced accessibility of K22 in the bicelle
environment, because this residue is located immediately af-
ter the end of helix 1 and is not fully accessible to water in
bicelles based on our previous NMR studies (12). Therefore,
we cross-linked 2H/15N S107C-EmrE with S-GMBS in
DDM micelles and then reconstituted the protein into
DLPC/DHPC bicelles. S-GMBS cross-linking causes some
additional peak shifts and line broadening on the water-
accessible surface of S107C-EmrE near the cross-linking
sites (Fig. 3, A and B). This line broadening may simply arise
due to proximity to the flexible cross-linker or cross-linking
may trap S107C-EmrE in a slightly different conformation
than the ground state of the unrestrained protein. However,
the overall similarity in chemical shift dispersion, peak num-
ber, and position between the spectra indicates that the over-
all structure is not significantly altered upon cross-linking.
However, unlike non-cross-linked S107C, S-GMBS
cross-linked S107C-EmrE has a striking absence of cross-
peaks in the ZZ-exchange experiment (Fig. 3, C and D).Biophysical Journal 107(3) 613–620
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FIGURE 2 S107C-EmrE structure and dynamics are similar to WT. (A) Overlay of 1H-15N TROSY-HSQC spectra of WT EmrE (black) and S107C-EmrE
(blue) bound to TPPþ in isotropic bicelles, pH 7, 45C. The two spectra are quite similar with localized chemical shift changes due to the four mutations
(C39S, C41S, C95S, S107C) plotted on the structure in (B). (C) Overlay of S107C-EmrE TROSY-HSQC (blue) with a TROSY ZZ-exchange plane at 80 ms
mixing time (red). Crosspeaks due to conformational exchange in the ZZ-exchange spectrum are connected with the autopeaks for several residues using
boxes (red dotted lines). These areas are enlarged in (D) for residues Q49, S64, and R82. To see this figure in color, go online.
616 Dutta et al.This result indicates that the interconversion of EmrE be-
tween open-in and open-out states is no longer detectable
upon antiparallel cross-linking with the relatively short
S-GMBS cross-linker. This supports our prediction that
S-GMBS can only cross-link one face of the antiparallel
EmrE dimer (the shorter closed face) and prevents the
protein from undergoing the full structural rearrangement
required for interconversion between the open-in and
open-out states. Because this conformational transition is
necessary for substrate efflux, we predicted that EmrE efflux
activity would be impaired by this antiparallel cross-linking.Antiparallel cross-linkers impair ethidium efflux
from E. coli
To investigate the effect of the loss of conformational
exchange due to cross-linking on the function of EmrE
in vivo, we measured Ethþ efflux using an in-cell assay
(Fig. 4) (28,29). BL21(DE3) E. coli cells overexpressing
WT EmrE show a higher rate of Ethþ efflux than control
cells without EmrE overexpression (13), demonstrating
that EmrE-dependent Ethþ efflux can be readily monitored.
We first performed several important control experiments
(Fig. 4 A). Both cys-less EmrE (gray line) and the single
cysteine containing construct S107C-EmrE (dark blue) ex-
hibited the same Ethþ efflux activity in vivo as WT EmrEBiophysical Journal 107(3) 613–620(black line), indicating that the cysteine mutations alone
do not alter function. This is consistent with the similarity
in structure and dynamics of uncross-linked S107C-EmrE
and WT EmrE in our solution NMR experiments (Fig. 2).
S107CK22R, which does not cross-link with the heterobi-
functional antiparallel cross-linkers in vitro (12) or in vivo
(Fig. 4 C) also has normal Ethþ efflux activity (Fig. 4 A, pur-
ple line). The lack of cross-linking by either S-GMBS or
SPDP with S107CK22R-EmrE confirms that cross-linking
occurs cleanly from S107C (the only cysteine present in
this construct) to K22 (the only lysine) and not the N-termi-
nus of the protein in vivo.
When testing the effect of cross-linking in vivo it is
necessary to control for more widespread effects of cross-
linker exposure on cellular function. We therefore used cys-
less-EmrE (C39S, C41S, C95S) and the non-cross-linkable
S107CK22R-EmrE for comparison in each cross-linking
experiment to ensure that the effects we observe are due
to specific cross-linking of S107C-EmrE. Addition of either
S-GMBS or SPDP has only a small effect on Ethþ efflux in
either case, and the results are similar for both cys-less and
S107CK22R-EmrE (Fig. 4 A, cyan, brown, green, orange
lines).
In the presence of the antiparallel cross-linkers S-GMBS
(Fig. 4 B, green) or SPDP (Fig. 4 B, red), Ethþ efflux by
S107C-EmrE expressing cells was reduced relative to cells
AB D
C
FIGURE 3 Antiparallel cross-linking of EmrE prevents conformational exchange. (A) Overlay of 1H-15N TROSY-HSQC spectra of S107C-EmrE (blue)
and S-GMBS cross-linked S107C-EmrE (green). Overall similarity between the spectra is good despite some peak shifts and line broadening (plotted on the
structure in B) indicating that cross-linking does not change the fold of the protein. (C) Overlay of 1H-15N TROSY-HSQC spectra of S-GMBS cross-linked
S107C-EmrE (green) and 80 msec TROSY ZZ-exchange plane (orange). Boxes (orange dotted) are drawn to connect the crosspeaks and the autopeaks
corresponding to a single residue based on the previous uncross-linked spectra but no crosspeaks are visible, indicating that conformational exchange is
not detectable under these conditions. Enlarged regions of these spectra are shown for Q49, S64, and R82 in (D) for comparison with Fig. 2. To see this
figure in color, go online.
Cross-Linking Disrupts Dynamics 617expressing the non-cross-linkable cysless-EmrE (Fig. 4 B,
brown, cyan) or S107CK22R-EmrE (Fig. 4 A). This reduced
activity is thus specific to S107C-EmrE cross-linking, and
the cell permeable cross-linker SPDP showed a larger effect.
Initial assessment of the degree of cross-linking in vivo from
simple purification of all the EmrE present in cells cross-
linked under identical conditions to those used for the
Ethþ efflux assay (Fig. 4 C) did not show the extent of
cross-linking expected from the significant inhibition of
activity in the Ethþ efflux assay (Fig. 4 B). We therefore
repeated the in vivo cross-linking under identical conditions,
but fractionated the cells to isolate the membrane-associated
EmrE from any present in inclusion bodies (Fig. 4 D). The
results are striking. Approximately 45% of the overex-
pressed EmrE under these conditions is present in inclusion
bodies and thus cannot contribute to efflux of Ethþ from the
cell. This fraction of EmrE is also not cross-linked by either
S-GMBS or the cell permeable SPDP. The EmrE embedded
in the membrane is cross-linked to a much higher degree, at
least 40–50%, with greater cross-linking by the cell perme-
able SPDP than S-GMBS. This is in much better agreement
with the degree of suppression of Ethþ efflux observed in
cells (Fig. 4 B). It is difficult to make a truly quantitative
comparison because it is difficult to cleanly define 100%activity and 0% activity. There are slight differences
whether cells overexpressing cysless- or S107CK22R-
EmrE in the presence of cross-linkers are used to represent
full EmrE-dependent efflux. There are also differences if the
initial Ethþ fluorescence at the start of the assay is used to
represent 0% efflux, or if the continued loading of Ethþ
from the external media during the time course of the assay
is accounted for, as in the control where CCCP is used to
dissipate the proton gradient. Although EmrE is overex-
pressed and represents the great majority of the fast Ethþ
efflux observed in these experiments (13), there are also
additional MDR transporters contributing to the background
level of Ethþ efflux in these cells. Given these caveats, semi-
quantitative agreement between the degree of cross-linking
in vivo with the suppression of efflux activity is consistent
with normal activity of the uncross-linked EmrE and com-
plete block of transport activity in cross-linked EmrE, as
hypothesized from the elimination of conformational ex-
change in the fully cross-linked NMR samples.
Together, these results show that cross-linking of the
EmrE dimer in an antiparallel topology suppresses EmrE ac-
tivity in its native E. coli. The NMR data indicate that EmrE
conformational exchange between the inward- and outward-
facing states is significantly suppressed by such antiparallelBiophysical Journal 107(3) 613–620
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FIGURE 4 Antiparallel cross-linking inhibits the function of EmrE. (A)
EmrE transport activity is monitored through the reduction in ethidium
(Ethþ) fluorescence as it is effluxed from E. coli. BL21 (DE3) cells overex-
pressing WT EmrE (black), S107C-EmrE (dark blue), S107CK22R-EmrE
(purple), and cysless-EmrE (gray line) show very similar efflux activity,
showing that the mutations alone do not affect EmrE function. Exposure
of the cells to the cross-linking reagents has a small effect on background
efflux as shown by control experiments with cells overexpressing non-
cross-linkable EmrE: cysless-EmrE in the presence of S-GMBS (cyan) or
SPDP (brown), or S107CK22R-EmrE in the presence of S-GMBS (green)
or SPDP (orange). The efflux of Ethþ could be prevented by dissipating the
Hþ gradient using a protonophore CCCP (pink line). (B) Ethþ efflux assay
showing the effect of the antiparallel cross-linkers S-GMBS (green line)
and SPDP (red line) on S107C-EmrE function. The cross-linking reagents
reduce background efflux as shown by the controls performed with cysless
Biophysical Journal 107(3) 613–620
618 Dutta et al.cross-linking, although the structure is only minimally
perturbed, providing a mechanistic explanation for the func-
tional impairment. This highlights the importance of protein
motion for transport activity and directly links cross-link-
ing-induced functional impairment to prevention of the
conformational transitions necessary for transport.Antiparallel cross-linking restricts the motion of
apo S107C-EmrE
EmrE is more structurally heterogeneous and dynamic in the
absence of polyaromatic cation substrate (apo state) based
on solid-state NMR linewidths of the active site residues,
Glu-14 (31), and electron paramagnetic resonance measure-
ments of spin-label mobility (30). Because EmrE is known
to change conformation to bind different substrates (32), this
plasticity of the apo state has been suggested to be a key
feature contributing to multidrug recognition. Solution
NMR spectra of EmrE in the absence of polyaromatic cation
substrate are of poor quality, with broad lines indicative of
structural heterogeneity or intermediate timescale exchange
(E. A. Morrison, unpublished data). Similar spectra are
observed for apo S107C-EmrE in bicelles at pH 7, 45C
(Fig. 5, blue spectrum). However, upon cross-linking with
S-GMBS, the number of discrete peaks visible in the spec-
trum increases (Fig. 5, green spectrum). A similar effect has
recently been reported for cross-linking with BMPS based
solely on the tryptophan side-chain region of the spectrum
(33). Here, we show that effects of cross-linking are
observed more globally across the entire backbone of the
protein. Due to the crowded nature of the spectrum and
chemical shift differences in the absence versus presence
of polyaromatic substrate it is difficult to assign many of
these peaks and the spectral quality is insufficient for de
novo assignment with standard NMR assignment protocols.
There are backbone and side-chain resonances that are well
resolved and relatively insensitive to mutation or substrate
identity based on our previous experiments (Fig. 5). Exam-
ining these regions reveals splitting of each apo peak into
two peaks upon cross-linking, with chemical shifts more
similar to the two peaks observed in the substrate-bound
state for these residues. The linewidths are still significantly
broader than in the substrate-bound state, and many reso-
nance remain undetectable due to either structural heteroge-
neity or dynamics. This suggests that antiparallel cross-
linking of EmrE partially restricts the motion of apoEmrE (dark blue, brown, cyan, as in A). (C) In vivo cross-linking of S107C-
EmrE by either SPDP (left) or S-GMBS (right) is abolished by K22R
confirming that the cross-link occurs between S107C and K22. (D) Approx-
imately 45% of the overexpressed S107C-EmrE is found in inclusion
bodies (IB) in vivo. Only the membrane localized S107C-EmrE (MEM)
is cross-linked by SGMBS (G) or SPDP (P). N indicates no cross-linker.
(E) SDS-PAGE gel illustrating the nearly complete cross-linking of
S107C-EmrE in vitro by the heterobifunctional cross-linkers S-GMBS
and SPDP. To see this figure in color, go online.
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FIGURE 5 Antiparallel cross-linking prevents the motion of apo EmrE.
1H-15N TROSY-HSQC spectra of apo S107C-EmrE (blue) and S-GMBS
cross-linked apo S107C-EmrE (green). Cross-linking of apo S107C-
EmrE inhibited the motion of the protein and increased the number of peaks
in S-GMBS cross-linked S107C-EmrE spectrum (green). The cross-linking
resulted in the splitting of well-resolved peaks of Gly-26 and Gly-9 (black
oval). The split peak patterns matched the peak pattern observed in sub-
strate-bound S107C-EmrE. The side chains of Trp-45 and Trp-76 also
showed peak splitting upon cross-linking. To see this figure in color, go
online.
Cross-Linking Disrupts Dynamics 619EmrE, as would be predicted for blocking conformational
exchange between inward- and outward-facing states
without preventing fluctuations around the lowest energy
structure.CONCLUSION
The results presented here explore the importance of confor-
mational exchange on the structure, dynamics, and function
of the small MDR transporter, EmrE. The alternating access
mechanism of transport requires that the transporter open
alternately to either side of the membrane to move substrate
across the membrane. Inhibition of this open-close transi-
tion should prevent the transporter from converting between
the different required conformations and thus impair trans-
port activity. This is exactly what we have observed in
our experiments. Cross-linking of EmrE in an antiparallel
fashion suppressed conformational exchange without signif-
icantly altering the protein structure. Most importantly, the
same cross-link impaired overall function of the transporter
in vivo, with good agreement between the extent to which
functional membrane-embedded EmrE was cross-linked
and the extent to which efflux activity was suppressed.
These results provide direct experimental data supporting
the hypothesis that preventing the motions required for
alternating access without altering the overall structure is
sufficient to impair function. Because our cross-link was
designed using the antiparallel dimer crystal structure, ourresults also provide additional evidence that the antiparallel
structure provides a good model for functional EmrE.
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